Kalik Tablet (Calididinogenase)

Adult dose

Administer 30~150 I.U. orally in 3 divided doses daily. Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients with bleeding conditions, such as those who have just experienced a cerebral hemorrhage. Additionally, this medication contains lactose, so individuals with genetic metabolic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. When taking this medication, allergic reactions such as skin rash or itching may occur, and if such symptoms appear, use should be discontinued immediately. Symptoms of rapid heartbeat may also occur rarely, so caution is necessary. Gastrointestinal symptoms may occur, including stomach discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation. Other rare symptoms may include a feeling of warmth, headache, heaviness in the head, drowsiness, and fatigue. For the elderly, special care, such as reducing the dosage, is necessary as physical functions may be weakened.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a sealed container that does not allow air in, and it is best to keep it at a temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness and safety.

Appearance

Red round enteric-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle